Equillium Reports Third Quarter 2019 Financial Results and Recent Highlights

San Diego Biotechnology Network
San Diego Biotechnology Network
Equillium Reports Third Quarter 2019 Financial Results and Recent Highlights
Loading
/

LA JOLLA, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for the third quarter 2019 and recent business highlights.


ADVERTISEMENT — Advertise With Biotech Networks